NZ523565A - Novel compounds and methods - Google Patents

Novel compounds and methods

Info

Publication number
NZ523565A
NZ523565A NZ523565A NZ52356501A NZ523565A NZ 523565 A NZ523565 A NZ 523565A NZ 523565 A NZ523565 A NZ 523565A NZ 52356501 A NZ52356501 A NZ 52356501A NZ 523565 A NZ523565 A NZ 523565A
Authority
NZ
New Zealand
Prior art keywords
alkyl
tetrahydro
group
aryl
pyran
Prior art date
Application number
NZ523565A
Other languages
English (en)
Inventor
William Butler Cowden
Bart Michael Eschler
Darren Ray March
Douglas John Francis
Sendaba Gerba
Gavin James Bartell
Brett Charlton
Original Assignee
Pharmaxis Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaxis Pty Ltd filed Critical Pharmaxis Pty Ltd
Publication of NZ523565A publication Critical patent/NZ523565A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NZ523565A 2000-07-11 2001-07-11 Novel compounds and methods NZ523565A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ8723A AUPQ872300A0 (en) 2000-07-11 2000-07-11 Compounds and methods
PCT/AU2001/000831 WO2002004472A1 (en) 2000-07-11 2001-07-11 Novel compounds and methods

Publications (1)

Publication Number Publication Date
NZ523565A true NZ523565A (en) 2004-03-26

Family

ID=3822788

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ523565A NZ523565A (en) 2000-07-11 2001-07-11 Novel compounds and methods

Country Status (7)

Country Link
US (1) US6878690B2 (cg-RX-API-DMAC7.html)
EP (1) EP1301522A4 (cg-RX-API-DMAC7.html)
JP (1) JP5035940B2 (cg-RX-API-DMAC7.html)
AU (1) AUPQ872300A0 (cg-RX-API-DMAC7.html)
CA (1) CA2415214C (cg-RX-API-DMAC7.html)
NZ (1) NZ523565A (cg-RX-API-DMAC7.html)
WO (1) WO2002004472A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1628987E (pt) 2003-05-20 2009-10-29 Pharmaxis Pty Ltd Compostos manose-6-fosfonato para o tratamento de doenças inflamatórias
BRPI0411691A (pt) * 2003-07-02 2006-12-26 Teva Gyogyszergyar Reszvenytar l-lisina de aztreonam e seus métodos de preparação
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
JP2012525369A (ja) * 2009-04-28 2012-10-22 ファーマキシス リミテッド 創傷および線維性障害の治療のためのホスホテトラヒドロピラン化合物
FR2992647B1 (fr) * 2012-07-02 2016-04-01 Centre Nat Rech Scient Derives de glycosides, leur preparation et leur utilisation comme groupes prosthetiques
NZ708928A (en) 2012-12-18 2020-04-24 Vertex Pharma Mannose derivatives for treating bacterial infections
AU2014248717B2 (en) 2013-03-12 2018-03-29 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
WO2016151989A1 (en) * 2015-03-24 2016-09-29 Okinawa Institute Of Science And Technology School Corporation C-glycoside derivatives
EP3959220A1 (en) * 2019-04-26 2022-03-02 Shanghai Yao Yuan Biotechnology Co., Ltd. Derivatives of glycero-manno-heptose phosphate and their use in modulating an immune response
CN112315950A (zh) * 2020-12-25 2021-02-05 西北农林科技大学 苯丙氨酸在制备防治葛根素注射剂诱发的血管内溶血的药物上的应用
CN113563136A (zh) * 2021-07-01 2021-10-29 胡国府 一种可溶性固态缓释肥料剂及其施用方法
CN116272899B (zh) * 2023-03-01 2025-04-04 西安理工大学 一种鳞片状中空纤维气凝胶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506210A (en) 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
AUPO309896A0 (en) 1996-10-18 1996-11-14 Australian National University, The Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity
GB9626450D0 (en) * 1996-12-20 1997-02-05 Oxford Glycosciences Uk Ltd Therapeutic compounds

Also Published As

Publication number Publication date
AUPQ872300A0 (en) 2000-08-03
EP1301522A1 (en) 2003-04-16
JP2004501985A (ja) 2004-01-22
JP5035940B2 (ja) 2012-09-26
EP1301522A4 (en) 2004-04-14
CA2415214C (en) 2009-12-22
WO2002004472A1 (en) 2002-01-17
US6878690B2 (en) 2005-04-12
US20030176363A1 (en) 2003-09-18
CA2415214A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
US6878690B2 (en) Compounds and methods
FI87790C (fi) Foerfarande foer framstaellning av epipodofyllotoxinglukosid-4'-fosfatderivat med antitumoer effekt
FI101705B (fi) Menetelmä aralifaattisesti N-substituoitujen aminoalkaanifosfiinihappo jen valmistamiseksi
JP6389463B2 (ja) 新規の抗菌性化合物およびその生物医学的用途
KR100951499B1 (ko) 플루오로옥신돌의 포스페이트 전구약물
CA2074020A1 (en) Trifluormethylbenzylphosphonates useful in treating osteoporosis
US5273990A (en) Phosphono substituted tetrazole derivatives
US5424441A (en) N-aralkyl-and N-heteroaralkyl-aminoalkanephosphinic acids
KR101327635B1 (ko) 포스폰산화 리파마이신, 및 그의 뼈 및 관절 감염의 저지및 치료 용도
US5376684A (en) Aminoalkanephosphinic acids and salts thereof
EP0570706A1 (en) Aryl and heteroaryl (phosphinylmethyl) phosphonate squalene synthetase inhibitors and method
AU2001270356B2 (en) Novel compounds and methods
CA2123768A1 (en) Benzopyran derivatives and their use
AU2001270356A1 (en) Novel compounds and methods
KR20130143091A (ko) 치료적 유용성을 가지는 수용체 조절제로서의 신규한 화합물
US7163932B2 (en) Aryldifluoromethylphosphonic acids for treatment of diabetes
US5219845A (en) Phosphonates as anti-inflammation agents
US7648966B2 (en) Mannose-6-phosphonate compounds for the treatment of inflammatory diseases
ITMI970730A1 (it) Coniugati di bis-fosfanati con funzionalita' alchilanti aventi attivita' antitumorale
FI85862B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fosfonylhydroxiacylproliner.
IE903452A1 (en) Phosphonic acid, a method for its manufacture, and its use as an active ingredient in medicines
AU2012242652A1 (en) Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
HUT72615A (en) Phosphono substituted tetrazole derivatives, process for preparing them, and pharmaceutical preparation containing them
PT100991A (pt) Derivados heterociclicos de acidos bifosfonicos, e processo para a sua preparacao
WO1992019627A2 (en) Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed